- AdventHealth Foundation Central Florida
As we look forward to the new year, the field of diabetes research continues to make significant strides. As we head into 2025, scientists and researchers bring us closer to a future where diabetes is no longer a debilitating condition.
Here are some of the top advances made in the treatment of diabetes:
New Type 1 Diabetes (T1D)Treatments
Glucagon-like peptide-1 (GLP-1) Receptor Agonists: This innovative class of drugs, known for stimulating insulin production and reducing glucose levels in Type 2 diabetes, is now being explored for its potential benefits in managing Type 1 diabetes. This promising research offers hope for improved treatment and better quality of life for those with T1D.
Artificial Pancreas Systems: These innovative devices seamlessly integrate continuous glucose monitoring with automated insulin delivery, mirroring the function of a healthy pancreas. By maintaining tight control over blood sugar levels, individuals with Type 1 diabetes (T1D) can experience improved quality of life and reduced risk of complications.
Stem Cell Therapy: With the power of regenerative medicine, researchers are investigating the potential of stem cells, particularly Mesenchymal Stem Cells (MSCs), to generate new insulin-producing beta cells. This groundbreaking approach could potentially restore the body's natural insulin production, offering hope for a future where insulin injections may no longer be necessary.
Islet Cell Transplantation: This procedure involves transplanting islet cells, which contain insulin-producing beta cells, from a donor into a person with T1D. By restoring the body's ability to produce insulin, this treatment offers a promising avenue for managing the disease.
Immunotherapies: These therapies aim to modulate the immune system's response, preventing it from attacking the body's own insulin-producing cells. By halting the progression of T1D, immunotherapies could significantly impact the lives of individuals with this condition.
Innovative Delivery Methods
Inhaled Insulin: This non-invasive approach delivers insulin directly to the lungs, offering a convenient alternative to injections.
Smart Insulin Pens: These advanced devices track insulin doses and transmit data to smartphone apps, empowering patients to make informed decisions about their treatment regimen.
Closed-loop Insulin Delivery Systems: Often referred to as the "artificial pancreas," these systems continuously monitor blood glucose levels and automatically adjust insulin delivery, minimizing the risk of hypoglycemia and hyperglycemia.
Cutting-Edge Research
Beta Cell Encapsulation: By encapsulating insulin-producing cells in a protective material, researchers aim to shield them from the immune system, potentially eliminating the need for immunosuppressive drugs after transplantation.
Gene Therapy: This experimental approach involves reprogramming other cells in the body to produce insulin, offering a potential cure for T1D by replacing the function of the destroyed beta cells.
As research continues to accelerate, the future of diabetes treatment holds immense promise. With these groundbreaking advancements, individuals with diabetes can look forward to greater control over their condition, improved quality of life, and, ultimately, a brighter future.
Recent News
On the day of his planned wedding, Mike Rounkles suffered a life-threatening heart attack. Thanks to fast action by Johnson County MED-ACT and AdventHealth Shawnee Mission team members, he received...
A first-of-its-kind report from global consulting firm Charles River Associates shows AdventHealth contributed over $16 billion in economic benefits to Florida in 2023.
Instead of relying on doctor's office visits every few weeks, the health system's new program prompts virtual visits for uncontrolled blood pressure.
AdventHealth is the first in Wesley Chapel to offer HYDROS™ Robotic System: A leading-edge AI-powered platform for Aquablation Therapy to treat BPH, or Benign Prostatic Hyperplasia.
The success of this case underscores the impact of early symptom recognition, coordinated EMS response, and hospital readiness.
AdventHealth South Overland Park has earned The Joint Commission’s Gold Seal of Approval® and the American Heart and Stroke Association’s Heart-Check mark for Primary Stroke Certification.
AdventHealth Zephyrhills honors first responders during EMS Week.
Hear from our doctors and nurses why they love our EMS partners, and join us in saying thank you.
Skin Cancer Awareness Month serves as a crucial reminder of the importance of vigilance in detecting and preventing skin cancer, the most common cancer affecting both men and women in the United...
A former patient of AdventHealth Littleton returned to recognize NICU moms on Mother’s Day.
Emergency Medical Services (EMS) Week is a time to honor the incredible dedication and exceptional skill of EMS providers who operate tirelessly to safeguard our communities.
The clinic is designed to increase access to care for people who are uninsured or underinsured.